Rac1 is required for Prkar1a-mediated Nf2 suppression in Schwann cell tumors
Authors:
Open Access
- 8 October 2012
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 32 (30) , 3491-3499
Abstract
Schwannomas are peripheral nerve sheath tumors that often occur in the setting of an inherited tumor predisposition syndrome, including neurofibromatosis types 1 (NF1) and 2 (NF2), familial schwannomatosis and Carney complex. Loss of the NF2 tumor suppressor (encoding NF2, or Merlin) is associated with upregulation of the Rac1 small GTPase, which is thought to have a key role in mediating tumor formation. In prior studies, we generated a mouse model of schwannomas by performing tissue-specific knockout (KO) of the Carney complex gene Prkar1a, which encodes the type 1A regulatory subunit of protein kinase A. These tumors exhibited down-regulation of Nf2 protein and an increase in activated Rac1. To assess the requirement for Rac1 in schwannoma formation, we generated a double KO (DKO) of Prkar1a and Rac1 in Schwann cells and monitored tumor formation. Loss of Rac1 reduced tumor formation by reducing proliferation and enhancing apoptosis. Surprisingly, the reduction of tumor formation was accompanied by re-expression of the Nf2 protein. Furthermore, activated Rac1 was able to downregulate Nf2 in vitro in a Pak-dependent manner. These in vivo data indicate that activation of Rac1 is responsible for suppression of Nf2 protein production; deficiency of Nf2 in Schwann cells leads to loss of cellular growth control and tumor formation. Further, PKA activation through mutation in Prkar1a is sufficient to initiate Rac1 signaling, with subsequent reduction of Nf2 and schwannomagenesis. Although in vitro evidence has shown that loss of Nf2 activates Rac1, our data indicate that signaling between Nf2 and Rac1 occurs in a bidirectional fashion, and these interactions are modulated by PKA.Keywords
This publication has 53 references indexed in Scilit:
- Neural Crest-Specific Loss of Prkar1a Causes Perinatal Lethality Resulting from Defects in Intramembranous OssificationMolecular Endocrinology, 2010
- What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: New FrontiersAmerican Journal of Medical Genetics Part A, 2010
- Inhibition of p21‐activated kinase 6 (PAK6) increases radiosensitivity of prostate cancer cellsThe Prostate, 2010
- PAK kinase regulates Rac GTPase and is a potential target in human schwannomasExperimental Neurology, 2009
- The function of RhoGTPases in axon ensheathment and myelinationGlia, 2008
- Essential and distinct roles for cdc42 and rac1 in the regulation of Schwann cell biology during peripheral nervous system developmentJournal of Cell Biology, 2007
- Myelination: all about Rac ‘n’ rollJournal of Cell Biology, 2007
- Germline Mutation of INI1/SMARCB1 in Familial SchwannomatosisThe American Journal of Human Genetics, 2007
- Mutant Products of the NF2 Tumor Suppressor Gene Are Degraded by the Ubiquitin-Proteasome PathwayJournal of Biological Chemistry, 2002
- The Neurofibromatosis Type 2 Gene Product, merlin, Reverses the F-Actin Cytoskeletal Defects in Primary Human Schwannoma CellsMolecular and Cellular Biology, 2002